de Montalembert M, Frangoul H. Risks and benefits of gene therapy and transplantation in sickle cell disease. Comment on: "HLA-haploidentical hematopoietic stem cell transplantation in patients with sickle cell disease: results from the phase II DREP-HAPLO trial". haematol [Internet]. 2020Sep.10 [cited 2026Jul.29];. Available from: https://haematologica.org/article/view/14318